You are here

Article Text

Article menu
Download PDFPDF
Treatment
A case manager plus psychoeducation reduced adverse outcomes in youth with type 1 diabetes

https://doi.org/10.1136/ebn.7.2.42

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Svoren BM, Butler D, Levine B-S, et al. Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial.Pediatrics 2003;112:914–22.OpenUrlAbstract/FREE Full Text

    Q In children and adolescents with type 1 diabetes, does a low intensity, non-medical intervention using a case manager to monitor and encourage routine diabetes care visits, with or without supplementation by psychoeducational modules, reduce acute adverse outcomes and improve glycaemic control?

    METHODS

    Embedded ImageDesign:

    randomised controlled trial.

    Embedded ImageAllocation:

    {not concealed}.*

    Embedded ImageBlinding:

    blinded {healthcare providers and data collectors}*.

    Embedded ImageFollow up period:

    24 months.

    Embedded ImageSetting:

    diabetes centre in Boston, Massachusetts, USA.

    Embedded ImagePatients:

    301 children and adolescents aged 7–16 years (mean age 12 y, 56% girls, mean duration of diabetes 5.2 y) who had had type 1 diabetes for >6 months. Inclusion criteria included ⩾1 outpatient medical visit in the previous year, no major psychiatric problems in the patient or parent, stable living environment, and intention for routine follow up at the study centre.

    Embedded ImageInterventions:

    low intensity, non-medical intervention using a …

    View Full Text

    Footnotes

    • ↵* Information provided by author.

    • For correspondence: Dr L M Laffel, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA. lori.laffeljoslin.harvard.edu

    • Sources of funding: National Institute of Diabetes and Digestive and Kidney Diseases, Charles H Hood Foundation, and Katherine Adler Astrove Youth Education Fund.